PPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target
Activation of peroxisome proliferator-activated receptors (PPARs), and particularly of PPARα and PPARγ, using selective agonists, is currently used in the treatment of metabolic diseases such as hypertriglyceridemia and type 2 diabetes mellitus. PPARα and PPARγ anti-inflammatory, antiproliferative...
Saved in:
| Main Authors: | Angela Tesse, Ramaroson Andriantsitohaina, Thierry Ragot |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2009/745821 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension
by: Yanli Jiang, et al.
Published: (2019-01-01) -
Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo.
by: Katrin Hack, et al.
Published: (2012-01-01) -
NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
by: Gerardo G. Mackenzie, et al.
Published: (2008-01-01) -
Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo
by: Larry G. Higgins, et al.
Published: (2012-01-01) -
Pharmacological inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) imparts selective leukemia cell death
by: Yingying Yang, et al.
Published: (2025-07-01)